LBX1 and breast carcinoma: The use of peptides to interfere with the interactions of proteins involved in cancer has been demonstrated successfully with iPeps comprising a conserved hexamotif and the N-terminus flanking sequence of the homeobox of the transcription factor Engrailed 1 (EN1) in basal-like breast cancer [18,19].